nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprazolam—CYP3A5—Gefitinib—lung cancer	0.0469	0.0717	CbGbCtD
Alprazolam—CYP3A5—Teniposide—lung cancer	0.0455	0.0695	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0338	0.0517	CbGbCtD
Alprazolam—CYP3A7—Paclitaxel—lung cancer	0.0338	0.0517	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0334	0.051	CbGbCtD
Alprazolam—CYP3A7—Irinotecan—lung cancer	0.0334	0.051	CbGbCtD
Alprazolam—CYP2C9—Gefitinib—lung cancer	0.0314	0.0481	CbGbCtD
Alprazolam—CYP2C9—Teniposide—lung cancer	0.0305	0.0466	CbGbCtD
Alprazolam—CYP3A5—Crizotinib—lung cancer	0.0287	0.0439	CbGbCtD
Alprazolam—CYP3A5—Erlotinib—lung cancer	0.0277	0.0424	CbGbCtD
Alprazolam—CYP3A5—Paclitaxel—lung cancer	0.0254	0.0388	CbGbCtD
Alprazolam—CYP3A5—Irinotecan—lung cancer	0.025	0.0383	CbGbCtD
Alprazolam—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0245	0.0374	CbGbCtD
Alprazolam—CYP3A7—Docetaxel—lung cancer	0.0245	0.0374	CbGbCtD
Alprazolam—CYP3A5—Etoposide—lung cancer	0.02	0.0306	CbGbCtD
Alprazolam—CYP3A4—Topotecan—lung cancer	0.02	0.0305	CbGbCtD
Alprazolam—CYP3A5—Docetaxel—lung cancer	0.0183	0.028	CbGbCtD
Alprazolam—CYP3A4—Gefitinib—lung cancer	0.0183	0.0279	CbGbCtD
Alprazolam—CYP3A4—Teniposide—lung cancer	0.0177	0.0271	CbGbCtD
Alprazolam—CYP2C9—Paclitaxel—lung cancer	0.017	0.026	CbGbCtD
Alprazolam—CYP3A4—Vinorelbine—lung cancer	0.0141	0.0215	CbGbCtD
Alprazolam—CYP2C9—Cisplatin—lung cancer	0.0137	0.0209	CbGbCtD
Alprazolam—CYP3A4—Crizotinib—lung cancer	0.0112	0.0171	CbGbCtD
Alprazolam—CYP3A4—Erlotinib—lung cancer	0.0108	0.0165	CbGbCtD
Alprazolam—CYP3A4—Paclitaxel—lung cancer	0.00989	0.0151	CbGbCtD
Alprazolam—CYP3A4—Irinotecan—lung cancer	0.00976	0.0149	CbGbCtD
Alprazolam—CYP3A4—Vinblastine—lung cancer	0.00868	0.0133	CbGbCtD
Alprazolam—CYP3A4—Etoposide—lung cancer	0.00782	0.0119	CbGbCtD
Alprazolam—CYP3A4—Docetaxel—lung cancer	0.00715	0.0109	CbGbCtD
Alprazolam—CYP3A4—Doxorubicin—lung cancer	0.00533	0.00815	CbGbCtD
Alprazolam—Flunitrazepam—UGT1A1—lung cancer	0.000518	0.149	CrCbGaD
Alprazolam—Flunitrazepam—CYP2A6—lung cancer	0.000325	0.0939	CrCbGaD
Alprazolam—Clonazepam—CYP2E1—lung cancer	0.000288	0.0831	CrCbGaD
Alprazolam—Flurazepam—CYP2A6—lung cancer	0.000261	0.0754	CrCbGaD
Alprazolam—Flunitrazepam—CYP2E1—lung cancer	0.000231	0.0667	CrCbGaD
Alprazolam—Nitrazepam—CYP2E1—lung cancer	0.000208	0.0602	CrCbGaD
Alprazolam—Ketazolam—ALB—lung cancer	0.000196	0.0566	CrCbGaD
Alprazolam—Ketazolam—ABCB1—lung cancer	0.000187	0.054	CrCbGaD
Alprazolam—Flurazepam—CYP2E1—lung cancer	0.000185	0.0535	CrCbGaD
Alprazolam—Midazolam—CYP2E1—lung cancer	0.000172	0.0496	CrCbGaD
Alprazolam—Clonazepam—ALB—lung cancer	0.000158	0.0456	CrCbGaD
Alprazolam—Diazepam—CYP2E1—lung cancer	0.000147	0.0425	CrCbGaD
Alprazolam—Dyspnoea—Etoposide—lung cancer	0.000135	0.00055	CcSEcCtD
Alprazolam—Somnolence—Etoposide—lung cancer	0.000134	0.000549	CcSEcCtD
Alprazolam—Hepatobiliary disease—Methotrexate—lung cancer	0.000134	0.000548	CcSEcCtD
Alprazolam—Insomnia—Paclitaxel—lung cancer	0.000134	0.000547	CcSEcCtD
Alprazolam—Epistaxis—Methotrexate—lung cancer	0.000134	0.000547	CcSEcCtD
Alprazolam—Hypersensitivity—Irinotecan—lung cancer	0.000134	0.000547	CcSEcCtD
Alprazolam—Convulsion—Docetaxel—lung cancer	0.000133	0.000545	CcSEcCtD
Alprazolam—Paraesthesia—Paclitaxel—lung cancer	0.000133	0.000543	CcSEcCtD
Alprazolam—Clobazam—ABCB1—lung cancer	0.000132	0.0382	CrCbGaD
Alprazolam—Dyspnoea—Paclitaxel—lung cancer	0.000132	0.000539	CcSEcCtD
Alprazolam—Somnolence—Paclitaxel—lung cancer	0.000132	0.000538	CcSEcCtD
Alprazolam—Decreased appetite—Etoposide—lung cancer	0.000131	0.000536	CcSEcCtD
Alprazolam—Chest pain—Docetaxel—lung cancer	0.000131	0.000535	CcSEcCtD
Alprazolam—Myalgia—Docetaxel—lung cancer	0.000131	0.000535	CcSEcCtD
Alprazolam—Arthralgia—Docetaxel—lung cancer	0.000131	0.000535	CcSEcCtD
Alprazolam—Nausea—Vinorelbine—lung cancer	0.000131	0.000534	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Etoposide—lung cancer	0.000131	0.000533	CcSEcCtD
Alprazolam—Dyspepsia—Paclitaxel—lung cancer	0.00013	0.000533	CcSEcCtD
Alprazolam—Body temperature increased—Cisplatin—lung cancer	0.00013	0.000533	CcSEcCtD
Alprazolam—Asthenia—Irinotecan—lung cancer	0.00013	0.000532	CcSEcCtD
Alprazolam—Fatigue—Etoposide—lung cancer	0.00013	0.000532	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00013	0.000531	CcSEcCtD
Alprazolam—Constipation—Etoposide—lung cancer	0.000129	0.000528	CcSEcCtD
Alprazolam—Dysuria—Doxorubicin—lung cancer	0.000129	0.000526	CcSEcCtD
Alprazolam—Decreased appetite—Paclitaxel—lung cancer	0.000129	0.000526	CcSEcCtD
Alprazolam—Dry mouth—Docetaxel—lung cancer	0.000128	0.000523	CcSEcCtD
Alprazolam—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000128	0.000523	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000128	0.000522	CcSEcCtD
Alprazolam—Fatigue—Paclitaxel—lung cancer	0.000128	0.000522	CcSEcCtD
Alprazolam—Hepatitis—Methotrexate—lung cancer	0.000127	0.00052	CcSEcCtD
Alprazolam—Pollakiuria—Doxorubicin—lung cancer	0.000127	0.00052	CcSEcCtD
Alprazolam—Asthenia—Gemcitabine—lung cancer	0.000127	0.000519	CcSEcCtD
Alprazolam—Constipation—Paclitaxel—lung cancer	0.000127	0.000517	CcSEcCtD
Alprazolam—Confusional state—Docetaxel—lung cancer	0.000127	0.000517	CcSEcCtD
Alprazolam—Urinary tract disorder—Methotrexate—lung cancer	0.000126	0.000514	CcSEcCtD
Alprazolam—Photosensitivity reaction—Doxorubicin—lung cancer	0.000126	0.000514	CcSEcCtD
Alprazolam—Oedema—Docetaxel—lung cancer	0.000126	0.000513	CcSEcCtD
Alprazolam—Weight increased—Doxorubicin—lung cancer	0.000125	0.000512	CcSEcCtD
Alprazolam—Pruritus—Gemcitabine—lung cancer	0.000125	0.000511	CcSEcCtD
Alprazolam—Urethral disorder—Methotrexate—lung cancer	0.000125	0.00051	CcSEcCtD
Alprazolam—Infection—Docetaxel—lung cancer	0.000125	0.00051	CcSEcCtD
Alprazolam—Weight decreased—Doxorubicin—lung cancer	0.000125	0.000509	CcSEcCtD
Alprazolam—Feeling abnormal—Etoposide—lung cancer	0.000125	0.000509	CcSEcCtD
Alprazolam—Diarrhoea—Irinotecan—lung cancer	0.000124	0.000508	CcSEcCtD
Alprazolam—Gastrointestinal pain—Etoposide—lung cancer	0.000124	0.000505	CcSEcCtD
Alprazolam—Shock—Docetaxel—lung cancer	0.000124	0.000505	CcSEcCtD
Alprazolam—Nervous system disorder—Docetaxel—lung cancer	0.000123	0.000503	CcSEcCtD
Alprazolam—Infestation NOS—Doxorubicin—lung cancer	0.000123	0.000502	CcSEcCtD
Alprazolam—Drowsiness—Doxorubicin—lung cancer	0.000123	0.000502	CcSEcCtD
Alprazolam—Infestation—Doxorubicin—lung cancer	0.000123	0.000502	CcSEcCtD
Alprazolam—Tachycardia—Docetaxel—lung cancer	0.000123	0.000501	CcSEcCtD
Alprazolam—Feeling abnormal—Paclitaxel—lung cancer	0.000122	0.000499	CcSEcCtD
Alprazolam—Skin disorder—Docetaxel—lung cancer	0.000122	0.000498	CcSEcCtD
Alprazolam—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000122	0.000498	CcSEcCtD
Alprazolam—Hypersensitivity—Cisplatin—lung cancer	0.000122	0.000496	CcSEcCtD
Alprazolam—Gastrointestinal pain—Paclitaxel—lung cancer	0.000121	0.000495	CcSEcCtD
Alprazolam—Diarrhoea—Gemcitabine—lung cancer	0.000121	0.000495	CcSEcCtD
Alprazolam—Erythema multiforme—Methotrexate—lung cancer	0.000121	0.000492	CcSEcCtD
Alprazolam—Dizziness—Irinotecan—lung cancer	0.00012	0.000491	CcSEcCtD
Alprazolam—Urticaria—Etoposide—lung cancer	0.00012	0.00049	CcSEcCtD
Alprazolam—Jaundice—Doxorubicin—lung cancer	0.00012	0.000489	CcSEcCtD
Alprazolam—Anorexia—Docetaxel—lung cancer	0.00012	0.000489	CcSEcCtD
Alprazolam—Abdominal pain—Etoposide—lung cancer	0.00012	0.000488	CcSEcCtD
Alprazolam—Body temperature increased—Etoposide—lung cancer	0.00012	0.000488	CcSEcCtD
Alprazolam—Eye disorder—Methotrexate—lung cancer	0.000119	0.000486	CcSEcCtD
Alprazolam—Tinnitus—Methotrexate—lung cancer	0.000119	0.000485	CcSEcCtD
Alprazolam—Asthenia—Cisplatin—lung cancer	0.000118	0.000483	CcSEcCtD
Alprazolam—Cardiac disorder—Methotrexate—lung cancer	0.000118	0.000483	CcSEcCtD
Alprazolam—Sweating—Doxorubicin—lung cancer	0.000118	0.000481	CcSEcCtD
Alprazolam—Urticaria—Paclitaxel—lung cancer	0.000118	0.000481	CcSEcCtD
Alprazolam—Hypotension—Docetaxel—lung cancer	0.000117	0.000479	CcSEcCtD
Alprazolam—Body temperature increased—Paclitaxel—lung cancer	0.000117	0.000478	CcSEcCtD
Alprazolam—Abdominal pain—Paclitaxel—lung cancer	0.000117	0.000478	CcSEcCtD
Alprazolam—Hepatobiliary disease—Doxorubicin—lung cancer	0.000116	0.000475	CcSEcCtD
Alprazolam—Epistaxis—Doxorubicin—lung cancer	0.000116	0.000473	CcSEcCtD
Alprazolam—Angiopathy—Methotrexate—lung cancer	0.000116	0.000472	CcSEcCtD
Alprazolam—Vomiting—Irinotecan—lung cancer	0.000116	0.000472	CcSEcCtD
Alprazolam—Mediastinal disorder—Methotrexate—lung cancer	0.000115	0.000469	CcSEcCtD
Alprazolam—Rash—Irinotecan—lung cancer	0.000115	0.000468	CcSEcCtD
Alprazolam—Dermatitis—Irinotecan—lung cancer	0.000114	0.000467	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000114	0.000467	CcSEcCtD
Alprazolam—Chills—Methotrexate—lung cancer	0.000114	0.000467	CcSEcCtD
Alprazolam—Headache—Irinotecan—lung cancer	0.000114	0.000465	CcSEcCtD
Alprazolam—Insomnia—Docetaxel—lung cancer	0.000114	0.000464	CcSEcCtD
Alprazolam—Diarrhoea—Cisplatin—lung cancer	0.000113	0.000461	CcSEcCtD
Alprazolam—Paraesthesia—Docetaxel—lung cancer	0.000113	0.000461	CcSEcCtD
Alprazolam—Vomiting—Gemcitabine—lung cancer	0.000113	0.00046	CcSEcCtD
Alprazolam—Dyspnoea—Docetaxel—lung cancer	0.000112	0.000457	CcSEcCtD
Alprazolam—Somnolence—Docetaxel—lung cancer	0.000112	0.000456	CcSEcCtD
Alprazolam—Mental disorder—Methotrexate—lung cancer	0.000112	0.000456	CcSEcCtD
Alprazolam—Rash—Gemcitabine—lung cancer	0.000112	0.000456	CcSEcCtD
Alprazolam—Dermatitis—Gemcitabine—lung cancer	0.000112	0.000455	CcSEcCtD
Alprazolam—Hypersensitivity—Etoposide—lung cancer	0.000111	0.000455	CcSEcCtD
Alprazolam—Malnutrition—Methotrexate—lung cancer	0.000111	0.000453	CcSEcCtD
Alprazolam—Headache—Gemcitabine—lung cancer	0.000111	0.000453	CcSEcCtD
Alprazolam—Dyspepsia—Docetaxel—lung cancer	0.000111	0.000451	CcSEcCtD
Alprazolam—Hepatitis—Doxorubicin—lung cancer	0.00011	0.000451	CcSEcCtD
Alprazolam—Hypoaesthesia—Doxorubicin—lung cancer	0.00011	0.000448	CcSEcCtD
Alprazolam—Nitrazepam—ABCB1—lung cancer	0.000109	0.0316	CrCbGaD
Alprazolam—Decreased appetite—Docetaxel—lung cancer	0.000109	0.000446	CcSEcCtD
Alprazolam—Hypersensitivity—Paclitaxel—lung cancer	0.000109	0.000446	CcSEcCtD
Alprazolam—Urinary tract disorder—Doxorubicin—lung cancer	0.000109	0.000445	CcSEcCtD
Alprazolam—Oedema peripheral—Doxorubicin—lung cancer	0.000109	0.000444	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Docetaxel—lung cancer	0.000108	0.000443	CcSEcCtD
Alprazolam—Asthenia—Etoposide—lung cancer	0.000108	0.000443	CcSEcCtD
Alprazolam—Connective tissue disorder—Doxorubicin—lung cancer	0.000108	0.000443	CcSEcCtD
Alprazolam—Fatigue—Docetaxel—lung cancer	0.000108	0.000442	CcSEcCtD
Alprazolam—Urethral disorder—Doxorubicin—lung cancer	0.000108	0.000442	CcSEcCtD
Alprazolam—Nausea—Irinotecan—lung cancer	0.000108	0.000441	CcSEcCtD
Alprazolam—Constipation—Docetaxel—lung cancer	0.000107	0.000439	CcSEcCtD
Alprazolam—Back pain—Methotrexate—lung cancer	0.000107	0.000438	CcSEcCtD
Alprazolam—Pruritus—Etoposide—lung cancer	0.000107	0.000437	CcSEcCtD
Alprazolam—Asthenia—Paclitaxel—lung cancer	0.000106	0.000434	CcSEcCtD
Alprazolam—Nausea—Gemcitabine—lung cancer	0.000105	0.000429	CcSEcCtD
Alprazolam—Vomiting—Cisplatin—lung cancer	0.000105	0.000428	CcSEcCtD
Alprazolam—Pruritus—Paclitaxel—lung cancer	0.000105	0.000428	CcSEcCtD
Alprazolam—Vision blurred—Methotrexate—lung cancer	0.000105	0.000427	CcSEcCtD
Alprazolam—Erythema multiforme—Doxorubicin—lung cancer	0.000104	0.000426	CcSEcCtD
Alprazolam—Rash—Cisplatin—lung cancer	0.000104	0.000425	CcSEcCtD
Alprazolam—Dermatitis—Cisplatin—lung cancer	0.000104	0.000424	CcSEcCtD
Alprazolam—Feeling abnormal—Docetaxel—lung cancer	0.000104	0.000423	CcSEcCtD
Alprazolam—Diarrhoea—Etoposide—lung cancer	0.000103	0.000422	CcSEcCtD
Alprazolam—Eye disorder—Doxorubicin—lung cancer	0.000103	0.000421	CcSEcCtD
Alprazolam—Ill-defined disorder—Methotrexate—lung cancer	0.000103	0.00042	CcSEcCtD
Alprazolam—Tinnitus—Doxorubicin—lung cancer	0.000103	0.00042	CcSEcCtD
Alprazolam—Gastrointestinal pain—Docetaxel—lung cancer	0.000103	0.000419	CcSEcCtD
Alprazolam—Cardiac disorder—Doxorubicin—lung cancer	0.000102	0.000418	CcSEcCtD
Alprazolam—Diarrhoea—Paclitaxel—lung cancer	0.000101	0.000414	CcSEcCtD
Alprazolam—Angiopathy—Doxorubicin—lung cancer	0.0001	0.000409	CcSEcCtD
Alprazolam—Malaise—Methotrexate—lung cancer	0.0001	0.000408	CcSEcCtD
Alprazolam—Dizziness—Etoposide—lung cancer	0.0001	0.000408	CcSEcCtD
Alprazolam—Vertigo—Methotrexate—lung cancer	9.97e-05	0.000407	CcSEcCtD
Alprazolam—Mediastinal disorder—Doxorubicin—lung cancer	9.95e-05	0.000406	CcSEcCtD
Alprazolam—Body temperature increased—Docetaxel—lung cancer	9.93e-05	0.000405	CcSEcCtD
Alprazolam—Abdominal pain—Docetaxel—lung cancer	9.93e-05	0.000405	CcSEcCtD
Alprazolam—Chills—Doxorubicin—lung cancer	9.9e-05	0.000404	CcSEcCtD
Alprazolam—Dizziness—Paclitaxel—lung cancer	9.8e-05	0.0004	CcSEcCtD
Alprazolam—Nausea—Cisplatin—lung cancer	9.8e-05	0.0004	CcSEcCtD
Alprazolam—Flurazepam—ABCB1—lung cancer	9.72e-05	0.0281	CrCbGaD
Alprazolam—Mental disorder—Doxorubicin—lung cancer	9.67e-05	0.000395	CcSEcCtD
Alprazolam—Convulsion—Methotrexate—lung cancer	9.61e-05	0.000392	CcSEcCtD
Alprazolam—Vomiting—Etoposide—lung cancer	9.61e-05	0.000392	CcSEcCtD
Alprazolam—Malnutrition—Doxorubicin—lung cancer	9.61e-05	0.000392	CcSEcCtD
Alprazolam—Rash—Etoposide—lung cancer	9.53e-05	0.000389	CcSEcCtD
Alprazolam—Dermatitis—Etoposide—lung cancer	9.52e-05	0.000389	CcSEcCtD
Alprazolam—Headache—Etoposide—lung cancer	9.47e-05	0.000387	CcSEcCtD
Alprazolam—Myalgia—Methotrexate—lung cancer	9.45e-05	0.000386	CcSEcCtD
Alprazolam—Chest pain—Methotrexate—lung cancer	9.45e-05	0.000386	CcSEcCtD
Alprazolam—Arthralgia—Methotrexate—lung cancer	9.45e-05	0.000386	CcSEcCtD
Alprazolam—Tension—Doxorubicin—lung cancer	9.43e-05	0.000385	CcSEcCtD
Alprazolam—Vomiting—Paclitaxel—lung cancer	9.42e-05	0.000385	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	9.38e-05	0.000383	CcSEcCtD
Alprazolam—Rash—Paclitaxel—lung cancer	9.35e-05	0.000382	CcSEcCtD
Alprazolam—Dermatitis—Paclitaxel—lung cancer	9.34e-05	0.000381	CcSEcCtD
Alprazolam—Discomfort—Methotrexate—lung cancer	9.33e-05	0.000381	CcSEcCtD
Alprazolam—Nervousness—Doxorubicin—lung cancer	9.33e-05	0.000381	CcSEcCtD
Alprazolam—Back pain—Doxorubicin—lung cancer	9.29e-05	0.000379	CcSEcCtD
Alprazolam—Headache—Paclitaxel—lung cancer	9.29e-05	0.000379	CcSEcCtD
Alprazolam—Hypersensitivity—Docetaxel—lung cancer	9.26e-05	0.000378	CcSEcCtD
Alprazolam—Muscle spasms—Doxorubicin—lung cancer	9.24e-05	0.000377	CcSEcCtD
Alprazolam—Confusional state—Methotrexate—lung cancer	9.13e-05	0.000373	CcSEcCtD
Alprazolam—Vision blurred—Doxorubicin—lung cancer	9.05e-05	0.00037	CcSEcCtD
Alprazolam—Asthenia—Docetaxel—lung cancer	9.01e-05	0.000368	CcSEcCtD
Alprazolam—Midazolam—ABCB1—lung cancer	9.01e-05	0.026	CrCbGaD
Alprazolam—Infection—Methotrexate—lung cancer	9e-05	0.000367	CcSEcCtD
Alprazolam—Nausea—Etoposide—lung cancer	8.98e-05	0.000367	CcSEcCtD
Alprazolam—Ill-defined disorder—Doxorubicin—lung cancer	8.91e-05	0.000364	CcSEcCtD
Alprazolam—Pruritus—Docetaxel—lung cancer	8.89e-05	0.000363	CcSEcCtD
Alprazolam—Nervous system disorder—Methotrexate—lung cancer	8.88e-05	0.000363	CcSEcCtD
Alprazolam—Agitation—Doxorubicin—lung cancer	8.83e-05	0.00036	CcSEcCtD
Alprazolam—Nausea—Paclitaxel—lung cancer	8.8e-05	0.000359	CcSEcCtD
Alprazolam—Skin disorder—Methotrexate—lung cancer	8.8e-05	0.000359	CcSEcCtD
Alprazolam—Hyperhidrosis—Methotrexate—lung cancer	8.75e-05	0.000357	CcSEcCtD
Alprazolam—Malaise—Doxorubicin—lung cancer	8.66e-05	0.000354	CcSEcCtD
Alprazolam—Vertigo—Doxorubicin—lung cancer	8.63e-05	0.000352	CcSEcCtD
Alprazolam—Anorexia—Methotrexate—lung cancer	8.63e-05	0.000352	CcSEcCtD
Alprazolam—Syncope—Doxorubicin—lung cancer	8.62e-05	0.000352	CcSEcCtD
Alprazolam—Diarrhoea—Docetaxel—lung cancer	8.6e-05	0.000351	CcSEcCtD
Alprazolam—Palpitations—Doxorubicin—lung cancer	8.49e-05	0.000347	CcSEcCtD
Alprazolam—Hypotension—Methotrexate—lung cancer	8.46e-05	0.000345	CcSEcCtD
Alprazolam—Loss of consciousness—Doxorubicin—lung cancer	8.44e-05	0.000345	CcSEcCtD
Alprazolam—Convulsion—Doxorubicin—lung cancer	8.32e-05	0.00034	CcSEcCtD
Alprazolam—Dizziness—Docetaxel—lung cancer	8.31e-05	0.000339	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Methotrexate—lung cancer	8.25e-05	0.000337	CcSEcCtD
Alprazolam—Insomnia—Methotrexate—lung cancer	8.19e-05	0.000334	CcSEcCtD
Alprazolam—Arthralgia—Doxorubicin—lung cancer	8.18e-05	0.000334	CcSEcCtD
Alprazolam—Chest pain—Doxorubicin—lung cancer	8.18e-05	0.000334	CcSEcCtD
Alprazolam—Myalgia—Doxorubicin—lung cancer	8.18e-05	0.000334	CcSEcCtD
Alprazolam—Anxiety—Doxorubicin—lung cancer	8.15e-05	0.000333	CcSEcCtD
Alprazolam—Paraesthesia—Methotrexate—lung cancer	8.13e-05	0.000332	CcSEcCtD
Alprazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.12e-05	0.000332	CcSEcCtD
Alprazolam—Diazepam—ALB—lung cancer	8.09e-05	0.0234	CrCbGaD
Alprazolam—Discomfort—Doxorubicin—lung cancer	8.08e-05	0.00033	CcSEcCtD
Alprazolam—Dyspnoea—Methotrexate—lung cancer	8.07e-05	0.00033	CcSEcCtD
Alprazolam—Somnolence—Methotrexate—lung cancer	8.05e-05	0.000329	CcSEcCtD
Alprazolam—Dry mouth—Doxorubicin—lung cancer	8e-05	0.000327	CcSEcCtD
Alprazolam—Vomiting—Docetaxel—lung cancer	7.99e-05	0.000326	CcSEcCtD
Alprazolam—Dyspepsia—Methotrexate—lung cancer	7.97e-05	0.000325	CcSEcCtD
Alprazolam—Rash—Docetaxel—lung cancer	7.92e-05	0.000323	CcSEcCtD
Alprazolam—Dermatitis—Docetaxel—lung cancer	7.91e-05	0.000323	CcSEcCtD
Alprazolam—Confusional state—Doxorubicin—lung cancer	7.91e-05	0.000323	CcSEcCtD
Alprazolam—Decreased appetite—Methotrexate—lung cancer	7.87e-05	0.000321	CcSEcCtD
Alprazolam—Headache—Docetaxel—lung cancer	7.87e-05	0.000321	CcSEcCtD
Alprazolam—Oedema—Doxorubicin—lung cancer	7.84e-05	0.00032	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Methotrexate—lung cancer	7.82e-05	0.000319	CcSEcCtD
Alprazolam—Fatigue—Methotrexate—lung cancer	7.81e-05	0.000319	CcSEcCtD
Alprazolam—Infection—Doxorubicin—lung cancer	7.79e-05	0.000318	CcSEcCtD
Alprazolam—Diazepam—ABCB1—lung cancer	7.72e-05	0.0223	CrCbGaD
Alprazolam—Shock—Doxorubicin—lung cancer	7.71e-05	0.000315	CcSEcCtD
Alprazolam—Nervous system disorder—Doxorubicin—lung cancer	7.69e-05	0.000314	CcSEcCtD
Alprazolam—Tachycardia—Doxorubicin—lung cancer	7.65e-05	0.000312	CcSEcCtD
Alprazolam—Skin disorder—Doxorubicin—lung cancer	7.62e-05	0.000311	CcSEcCtD
Alprazolam—Hyperhidrosis—Doxorubicin—lung cancer	7.58e-05	0.000309	CcSEcCtD
Alprazolam—Anorexia—Doxorubicin—lung cancer	7.47e-05	0.000305	CcSEcCtD
Alprazolam—Nausea—Docetaxel—lung cancer	7.46e-05	0.000305	CcSEcCtD
Alprazolam—Feeling abnormal—Methotrexate—lung cancer	7.46e-05	0.000305	CcSEcCtD
Alprazolam—Gastrointestinal pain—Methotrexate—lung cancer	7.4e-05	0.000302	CcSEcCtD
Alprazolam—Hypotension—Doxorubicin—lung cancer	7.33e-05	0.000299	CcSEcCtD
Alprazolam—Urticaria—Methotrexate—lung cancer	7.19e-05	0.000294	CcSEcCtD
Alprazolam—Abdominal pain—Methotrexate—lung cancer	7.16e-05	0.000292	CcSEcCtD
Alprazolam—Body temperature increased—Methotrexate—lung cancer	7.16e-05	0.000292	CcSEcCtD
Alprazolam—Musculoskeletal discomfort—Doxorubicin—lung cancer	7.14e-05	0.000292	CcSEcCtD
Alprazolam—Insomnia—Doxorubicin—lung cancer	7.09e-05	0.00029	CcSEcCtD
Alprazolam—Paraesthesia—Doxorubicin—lung cancer	7.04e-05	0.000287	CcSEcCtD
Alprazolam—Dyspnoea—Doxorubicin—lung cancer	6.99e-05	0.000285	CcSEcCtD
Alprazolam—Somnolence—Doxorubicin—lung cancer	6.97e-05	0.000285	CcSEcCtD
Alprazolam—Dyspepsia—Doxorubicin—lung cancer	6.9e-05	0.000282	CcSEcCtD
Alprazolam—Decreased appetite—Doxorubicin—lung cancer	6.82e-05	0.000278	CcSEcCtD
Alprazolam—Gastrointestinal disorder—Doxorubicin—lung cancer	6.77e-05	0.000276	CcSEcCtD
Alprazolam—Fatigue—Doxorubicin—lung cancer	6.76e-05	0.000276	CcSEcCtD
Alprazolam—Constipation—Doxorubicin—lung cancer	6.71e-05	0.000274	CcSEcCtD
Alprazolam—Hypersensitivity—Methotrexate—lung cancer	6.67e-05	0.000272	CcSEcCtD
Alprazolam—Asthenia—Methotrexate—lung cancer	6.5e-05	0.000265	CcSEcCtD
Alprazolam—Feeling abnormal—Doxorubicin—lung cancer	6.46e-05	0.000264	CcSEcCtD
Alprazolam—Gastrointestinal pain—Doxorubicin—lung cancer	6.41e-05	0.000262	CcSEcCtD
Alprazolam—Pruritus—Methotrexate—lung cancer	6.41e-05	0.000262	CcSEcCtD
Alprazolam—Urticaria—Doxorubicin—lung cancer	6.23e-05	0.000254	CcSEcCtD
Alprazolam—Abdominal pain—Doxorubicin—lung cancer	6.2e-05	0.000253	CcSEcCtD
Alprazolam—Body temperature increased—Doxorubicin—lung cancer	6.2e-05	0.000253	CcSEcCtD
Alprazolam—Diarrhoea—Methotrexate—lung cancer	6.2e-05	0.000253	CcSEcCtD
Alprazolam—Dizziness—Methotrexate—lung cancer	5.99e-05	0.000244	CcSEcCtD
Alprazolam—Hypersensitivity—Doxorubicin—lung cancer	5.78e-05	0.000236	CcSEcCtD
Alprazolam—Vomiting—Methotrexate—lung cancer	5.76e-05	0.000235	CcSEcCtD
Alprazolam—Rash—Methotrexate—lung cancer	5.71e-05	0.000233	CcSEcCtD
Alprazolam—Dermatitis—Methotrexate—lung cancer	5.7e-05	0.000233	CcSEcCtD
Alprazolam—Headache—Methotrexate—lung cancer	5.67e-05	0.000232	CcSEcCtD
Alprazolam—Asthenia—Doxorubicin—lung cancer	5.63e-05	0.00023	CcSEcCtD
Alprazolam—Pruritus—Doxorubicin—lung cancer	5.55e-05	0.000226	CcSEcCtD
Alprazolam—Nausea—Methotrexate—lung cancer	5.38e-05	0.00022	CcSEcCtD
Alprazolam—Diarrhoea—Doxorubicin—lung cancer	5.36e-05	0.000219	CcSEcCtD
Alprazolam—Dizziness—Doxorubicin—lung cancer	5.18e-05	0.000212	CcSEcCtD
Alprazolam—Vomiting—Doxorubicin—lung cancer	4.99e-05	0.000204	CcSEcCtD
Alprazolam—Rash—Doxorubicin—lung cancer	4.94e-05	0.000202	CcSEcCtD
Alprazolam—Dermatitis—Doxorubicin—lung cancer	4.94e-05	0.000202	CcSEcCtD
Alprazolam—Headache—Doxorubicin—lung cancer	4.91e-05	0.000201	CcSEcCtD
Alprazolam—Nausea—Doxorubicin—lung cancer	4.66e-05	0.00019	CcSEcCtD
Alprazolam—CYP3A5—Metabolism—GSTM2—lung cancer	2.99e-05	0.000307	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTA2—lung cancer	2.97e-05	0.000305	CbGpPWpGaD
Alprazolam—GABRA2—Transmission across Chemical Synapses—HRAS—lung cancer	2.97e-05	0.000305	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ATP5H—lung cancer	2.96e-05	0.000304	CbGpPWpGaD
Alprazolam—GABRA1—SIDS Susceptibility Pathways—IL6—lung cancer	2.95e-05	0.000304	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.95e-05	0.000303	CbGpPWpGaD
Alprazolam—GABRB3—Transmission across Chemical Synapses—HRAS—lung cancer	2.95e-05	0.000303	CbGpPWpGaD
Alprazolam—CYP2C9—Biological oxidations—POMC—lung cancer	2.95e-05	0.000303	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—MTMR3—lung cancer	2.91e-05	0.000299	CbGpPWpGaD
Alprazolam—GABRG2—Transmission across Chemical Synapses—HRAS—lung cancer	2.9e-05	0.000298	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTA1—lung cancer	2.87e-05	0.000294	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCC3—lung cancer	2.83e-05	0.000291	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PGAM1—lung cancer	2.83e-05	0.000291	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.8e-05	0.000287	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.75e-05	0.000283	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AKR1C1—lung cancer	2.74e-05	0.000282	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—CREBBP—lung cancer	2.72e-05	0.000279	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	2.72e-05	0.000279	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.71e-05	0.000279	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2A7—lung cancer	2.7e-05	0.000278	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—CREBBP—lung cancer	2.67e-05	0.000274	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—UGT1A1—lung cancer	2.66e-05	0.000274	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—SDC4—lung cancer	2.64e-05	0.000272	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—APOA1—lung cancer	2.64e-05	0.000272	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PLBD1—lung cancer	2.63e-05	0.000271	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.62e-05	0.00027	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—ALB—lung cancer	2.62e-05	0.000269	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.61e-05	0.000268	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—CREBBP—lung cancer	2.61e-05	0.000268	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.59e-05	0.000266	CbGpPWpGaD
Alprazolam—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.57e-05	0.000264	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GNG11—lung cancer	2.57e-05	0.000264	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—CREBBP—lung cancer	2.56e-05	0.000263	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—ALB—lung cancer	2.54e-05	0.000261	CbGpPWpGaD
Alprazolam—GABRA1—Transmission across Chemical Synapses—HRAS—lung cancer	2.53e-05	0.00026	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—ALB—lung cancer	2.5e-05	0.000257	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—ALB—lung cancer	2.46e-05	0.000252	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALDOA—lung cancer	2.45e-05	0.000251	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—ALB—lung cancer	2.44e-05	0.000251	CbGpPWpGaD
Alprazolam—GABRB2—Neuronal System—HRAS—lung cancer	2.43e-05	0.000249	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HSD17B10—lung cancer	2.41e-05	0.000248	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTA3—lung cancer	2.41e-05	0.000247	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—RRM1—lung cancer	2.41e-05	0.000247	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—ALB—lung cancer	2.4e-05	0.000246	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NCOA3—lung cancer	2.37e-05	0.000244	CbGpPWpGaD
Alprazolam—GABRB2—Transmembrane transport of small molecules—RAF1—lung cancer	2.37e-05	0.000243	CbGpPWpGaD
Alprazolam—GABRA5—Neuronal System—HRAS—lung cancer	2.36e-05	0.000242	CbGpPWpGaD
Alprazolam—GABRA3—Neuronal System—HRAS—lung cancer	2.31e-05	0.000238	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCG2—lung cancer	2.31e-05	0.000237	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ADCY1—lung cancer	2.31e-05	0.000237	CbGpPWpGaD
Alprazolam—GABRA5—Transmembrane transport of small molecules—RAF1—lung cancer	2.3e-05	0.000236	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AZIN2—lung cancer	2.29e-05	0.000236	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.29e-05	0.000236	CbGpPWpGaD
Alprazolam—GABRA2—Neuronal System—HRAS—lung cancer	2.27e-05	0.000234	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ENO2—lung cancer	2.26e-05	0.000233	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—HPGDS—lung cancer	2.26e-05	0.000233	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—B4GALT5—lung cancer	2.26e-05	0.000233	CbGpPWpGaD
Alprazolam—GABRA3—Transmembrane transport of small molecules—RAF1—lung cancer	2.26e-05	0.000232	CbGpPWpGaD
Alprazolam—GABRB3—Neuronal System—HRAS—lung cancer	2.26e-05	0.000232	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PPP2R1B—lung cancer	2.25e-05	0.000231	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CKB—lung cancer	2.24e-05	0.00023	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—lung cancer	2.24e-05	0.00023	CbGpPWpGaD
Alprazolam—GABRA2—Transmembrane transport of small molecules—RAF1—lung cancer	2.22e-05	0.000228	CbGpPWpGaD
Alprazolam—GABRG2—Neuronal System—HRAS—lung cancer	2.22e-05	0.000228	CbGpPWpGaD
Alprazolam—GABRB3—Transmembrane transport of small molecules—RAF1—lung cancer	2.21e-05	0.000227	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTA4—lung cancer	2.2e-05	0.000226	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTT1—lung cancer	2.2e-05	0.000226	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GCLC—lung cancer	2.17e-05	0.000223	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP2A6—lung cancer	2.17e-05	0.000223	CbGpPWpGaD
Alprazolam—GABRG2—Transmembrane transport of small molecules—RAF1—lung cancer	2.17e-05	0.000223	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTA2—lung cancer	2.15e-05	0.000221	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CNDP2—lung cancer	2.11e-05	0.000216	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTM2—lung cancer	2.11e-05	0.000216	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—ALB—lung cancer	2.09e-05	0.000215	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTA1—lung cancer	2.07e-05	0.000213	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ENO1—lung cancer	2.06e-05	0.000212	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—MTMR3—lung cancer	2.05e-05	0.000211	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCC3—lung cancer	2.05e-05	0.00021	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PGAM1—lung cancer	2e-05	0.000205	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKR1C1—lung cancer	1.98e-05	0.000204	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ATP5H—lung cancer	1.95e-05	0.0002	CbGpPWpGaD
Alprazolam—CYP3A4—Biological oxidations—POMC—lung cancer	1.94e-05	0.0002	CbGpPWpGaD
Alprazolam—GABRA1—Neuronal System—HRAS—lung cancer	1.94e-05	0.000199	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—UGT1A1—lung cancer	1.93e-05	0.000198	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2A7—lung cancer	1.9e-05	0.000196	CbGpPWpGaD
Alprazolam—GABRA1—Transmembrane transport of small molecules—RAF1—lung cancer	1.89e-05	0.000195	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—SDC4—lung cancer	1.86e-05	0.000192	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GNG11—lung cancer	1.86e-05	0.000191	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP2E1—lung cancer	1.85e-05	0.00019	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—NQO1—lung cancer	1.83e-05	0.000188	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALDOA—lung cancer	1.77e-05	0.000182	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PLBD1—lung cancer	1.74e-05	0.000179	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NCOA3—lung cancer	1.72e-05	0.000176	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA3—lung cancer	1.7e-05	0.000174	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—RRM1—lung cancer	1.7e-05	0.000174	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ADCY1—lung cancer	1.67e-05	0.000172	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCG2—lung cancer	1.67e-05	0.000172	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—STK11—lung cancer	1.65e-05	0.000169	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ENO2—lung cancer	1.64e-05	0.000168	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—HPGDS—lung cancer	1.64e-05	0.000168	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PPP2R1B—lung cancer	1.63e-05	0.000167	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—B4GALT5—lung cancer	1.6e-05	0.000164	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HSD17B10—lung cancer	1.59e-05	0.000163	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTT1—lung cancer	1.59e-05	0.000163	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2A6—lung cancer	1.57e-05	0.000161	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GCLC—lung cancer	1.57e-05	0.000161	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA4—lung cancer	1.55e-05	0.00016	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTP1—lung cancer	1.52e-05	0.000156	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.52e-05	0.000156	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA2—lung cancer	1.51e-05	0.000155	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ENO1—lung cancer	1.49e-05	0.000153	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CAT—lung cancer	1.48e-05	0.000152	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CKB—lung cancer	1.48e-05	0.000152	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTA1—lung cancer	1.46e-05	0.00015	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCC3—lung cancer	1.44e-05	0.000148	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ABCB1—lung cancer	1.44e-05	0.000148	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—TYMS—lung cancer	1.42e-05	0.000145	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—GSTM1—lung cancer	1.4e-05	0.000144	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKR1C1—lung cancer	1.4e-05	0.000144	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CNDP2—lung cancer	1.39e-05	0.000143	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTM2—lung cancer	1.39e-05	0.000143	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—UGT1A1—lung cancer	1.36e-05	0.000139	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—MTMR3—lung cancer	1.35e-05	0.000139	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP2E1—lung cancer	1.33e-05	0.000137	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CYP1A1—lung cancer	1.33e-05	0.000136	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—NQO1—lung cancer	1.32e-05	0.000136	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PGAM1—lung cancer	1.32e-05	0.000135	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ERCC2—lung cancer	1.32e-05	0.000135	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GNG11—lung cancer	1.31e-05	0.000134	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.3e-05	0.000134	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2A7—lung cancer	1.26e-05	0.000129	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALDOA—lung cancer	1.25e-05	0.000128	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—SDC4—lung cancer	1.23e-05	0.000126	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NCOA3—lung cancer	1.21e-05	0.000124	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—STK11—lung cancer	1.19e-05	0.000122	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.19e-05	0.000122	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ADCY1—lung cancer	1.18e-05	0.000121	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCG2—lung cancer	1.18e-05	0.000121	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—HPGDS—lung cancer	1.15e-05	0.000119	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ENO2—lung cancer	1.15e-05	0.000119	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.15e-05	0.000118	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—APOA1—lung cancer	1.14e-05	0.000117	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.13e-05	0.000116	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—RRM1—lung cancer	1.12e-05	0.000115	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA3—lung cancer	1.12e-05	0.000115	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTT1—lung cancer	1.12e-05	0.000115	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GCLC—lung cancer	1.11e-05	0.000114	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2A6—lung cancer	1.11e-05	0.000114	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.1e-05	0.000113	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTP1—lung cancer	1.1e-05	0.000113	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CAT—lung cancer	1.07e-05	0.00011	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—B4GALT5—lung cancer	1.05e-05	0.000108	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ENO1—lung cancer	1.05e-05	0.000108	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.05e-05	0.000107	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ABCB1—lung cancer	1.04e-05	0.000107	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CG—lung cancer	1.04e-05	0.000107	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.03e-05	0.000106	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA4—lung cancer	1.02e-05	0.000105	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—TYMS—lung cancer	1.02e-05	0.000105	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—GSTM1—lung cancer	1.01e-05	0.000104	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA2—lung cancer	9.98e-06	0.000103	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—POMC—lung cancer	9.89e-06	0.000102	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—CREBBP—lung cancer	9.63e-06	9.9e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTA1—lung cancer	9.63e-06	9.89e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CYP1A1—lung cancer	9.59e-06	9.85e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCC3—lung cancer	9.52e-06	9.78e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ERCC2—lung cancer	9.51e-06	9.77e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP2E1—lung cancer	9.41e-06	9.67e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—NQO1—lung cancer	9.3e-06	9.56e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKR1C1—lung cancer	9.22e-06	9.47e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CD—lung cancer	9.13e-06	9.39e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.11e-06	9.36e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.03e-06	9.27e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—ALB—lung cancer	9.02e-06	9.27e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—UGT1A1—lung cancer	8.95e-06	9.2e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GNG11—lung cancer	8.63e-06	8.87e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—STK11—lung cancer	8.39e-06	8.62e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—APOA1—lung cancer	8.23e-06	8.45e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALDOA—lung cancer	8.22e-06	8.44e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NCOA3—lung cancer	7.98e-06	8.2e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CB—lung cancer	7.96e-06	8.18e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTGS2—lung cancer	7.89e-06	8.11e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.87e-06	8.09e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ADCY1—lung cancer	7.76e-06	7.98e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCG2—lung cancer	7.76e-06	7.98e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTP1—lung cancer	7.76e-06	7.97e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—HPGDS—lung cancer	7.61e-06	7.82e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ENO2—lung cancer	7.61e-06	7.82e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.56e-06	7.77e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CAT—lung cancer	7.55e-06	7.76e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CG—lung cancer	7.51e-06	7.72e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.51e-06	7.71e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTT1—lung cancer	7.38e-06	7.59e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ABCB1—lung cancer	7.34e-06	7.55e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2A6—lung cancer	7.3e-06	7.5e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GCLC—lung cancer	7.3e-06	7.5e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—TYMS—lung cancer	7.21e-06	7.41e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—POMC—lung cancer	7.15e-06	7.35e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—GSTM1—lung cancer	7.13e-06	7.33e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—CREBBP—lung cancer	6.96e-06	7.16e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ENO1—lung cancer	6.92e-06	7.11e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PTEN—lung cancer	6.88e-06	7.07e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CYP1A1—lung cancer	6.76e-06	6.95e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ERCC2—lung cancer	6.7e-06	6.89e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CD—lung cancer	6.6e-06	6.78e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—EP300—lung cancer	6.56e-06	6.74e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—ALB—lung cancer	6.52e-06	6.7e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP2E1—lung cancer	6.2e-06	6.38e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—NQO1—lung cancer	6.13e-06	6.3e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—APOA1—lung cancer	5.8e-06	5.96e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CB—lung cancer	5.75e-06	5.91e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTGS2—lung cancer	5.7e-06	5.86e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.55e-06	5.71e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—STK11—lung cancer	5.53e-06	5.68e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CG—lung cancer	5.29e-06	5.44e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTP1—lung cancer	5.12e-06	5.26e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—POMC—lung cancer	5.04e-06	5.18e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CAT—lung cancer	4.98e-06	5.12e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PTEN—lung cancer	4.97e-06	5.11e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—CREBBP—lung cancer	4.91e-06	5.04e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—PIK3CA—lung cancer	4.85e-06	4.99e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ABCB1—lung cancer	4.84e-06	4.98e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—TYMS—lung cancer	4.76e-06	4.89e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—EP300—lung cancer	4.74e-06	4.87e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—GSTM1—lung cancer	4.7e-06	4.83e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CD—lung cancer	4.65e-06	4.78e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—ALB—lung cancer	4.59e-06	4.72e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CYP1A1—lung cancer	4.46e-06	4.58e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ERCC2—lung cancer	4.42e-06	4.54e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CB—lung cancer	4.06e-06	4.17e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTGS2—lung cancer	4.02e-06	4.13e-05	CbGpPWpGaD
Alprazolam—CYP3A7—Metabolism—AKT1—lung cancer	3.96e-06	4.07e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—APOA1—lung cancer	3.82e-06	3.93e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—PIK3CA—lung cancer	3.51e-06	3.6e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PTEN—lung cancer	3.51e-06	3.6e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CG—lung cancer	3.49e-06	3.59e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—EP300—lung cancer	3.34e-06	3.44e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—POMC—lung cancer	3.32e-06	3.42e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—CREBBP—lung cancer	3.24e-06	3.33e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CD—lung cancer	3.07e-06	3.15e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—ALB—lung cancer	3.03e-06	3.11e-05	CbGpPWpGaD
Alprazolam—CYP3A5—Metabolism—AKT1—lung cancer	2.87e-06	2.94e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CB—lung cancer	2.68e-06	2.75e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTGS2—lung cancer	2.65e-06	2.72e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—PIK3CA—lung cancer	2.47e-06	2.54e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PTEN—lung cancer	2.31e-06	2.38e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—EP300—lung cancer	2.2e-06	2.27e-05	CbGpPWpGaD
Alprazolam—CYP2C9—Metabolism—AKT1—lung cancer	2.02e-06	2.08e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—PIK3CA—lung cancer	1.63e-06	1.68e-05	CbGpPWpGaD
Alprazolam—CYP3A4—Metabolism—AKT1—lung cancer	1.33e-06	1.37e-05	CbGpPWpGaD
